Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results

Found 58 matches for

Help us protect people with type 2 diabetes from heart attacks, strokes and other health problems

ASCEND PLUS is a UK-wide clinical trial testing a tablet medication called oral semaglutide, which might help to protect against heart attacks, strokes and circulatory problems in people with type 2 diabetes

Initial information

Participant Information

How can we protect people with type 2 diabetes from heart attacks, strokes and other health problems?

Public involvement

Contact

Accessibility

Cookies

Data protection information for patients in England with type 2 diabetes

Data protection information for people who are taking part in ASCEND PLUS

Privacy Notice for ASCEND PLUS trial staff and investigators

Data protection

Participants